Success Stories Now, But At Risk

Success Stories Now, But At Risk

09.21.11 | By Kate Connors

This week, an op-ed by John C. Lechleiter - the president, chairman and CEO of Eli Lilly and Company, one of PhRMA's member companies - highlighted what he calls "two success stories," one being the jobs supported in Indiana by the innovative life sciences sector there and the other being the "efficiency and satisfaction" associated with Medicare Part D, the prescription drug benefit.

What do these two success stories have in common? According to Lechleiter, they could both suffer from some policy proposals that would change the drug benefit. To read how proposed changes to Part D could limit access and stymie innovation, check out the op-ed in its entirety here.

More On PhRMA — powered by PhRMApedia


Cost in Context